Rucaparib maintenance treatment for recurrent ovarian carcinoma after response to platinum therapy (ARIEL3): a randomised, double-blind, placebo-controlled, phase 3 trial
Research output: Contribution to journal › Article › peer-review
994Citations
(Scopus)
Fingerprint
Dive into the research topics of 'Rucaparib maintenance treatment for recurrent ovarian carcinoma after response to platinum therapy (ARIEL3): a randomised, double-blind, placebo-controlled, phase 3 trial'. Together they form a unique fingerprint.